190 related articles for article (PubMed ID: 2452745)
1. The glioblastoma-derived T cell suppressor factor/transforming growth factor-beta 2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor.
Siepl C; Bodmer S; Frei K; MacDonald HR; De Martin R; Hofer E; Fontana A
Eur J Immunol; 1988 Apr; 18(4):593-600. PubMed ID: 2452745
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.
Bodmer S; Strommer K; Frei K; Siepl C; de Tribolet N; Heid I; Fontana A
J Immunol; 1989 Nov; 143(10):3222-9. PubMed ID: 2809198
[TBL] [Abstract][Full Text] [Related]
3. Feedback regulation of immune suppression by a suppressor factor.
Ikezawa Z; Arden B; Nagy ZA; Klein J
Eur J Immunol; 1984 Aug; 14(8):681-6. PubMed ID: 6205879
[TBL] [Abstract][Full Text] [Related]
4. Cloned helper T lymphocytes exposed to interleukin 2 become unresponsive to antigen and concanavalin A but not to calcium ionophore and phorbol ester.
Otten G; Wilde DB; Prystowsky MB; Olshan JS; Rabin H; Henderson LE; Fitch FW
Eur J Immunol; 1986 Mar; 16(3):217-25. PubMed ID: 2937640
[TBL] [Abstract][Full Text] [Related]
5. An antigen-independent physiological activation pathway for L3T4+ T lymphocytes.
Germann T; Huhn H; Zimmermann F; Rüde E
Eur J Immunol; 1987 Jun; 17(6):775-81. PubMed ID: 2954826
[TBL] [Abstract][Full Text] [Related]
6. Antigen-specific suppressor factors of noncytotoxic CD8+ suppressor T cells downregulate antibody responses also to unrelated antigens when the latter are presented as covalently linked adducts with the specific antigen.
Bitoh S; Takata M; Maiti PK; Holford-Strevens V; Kierek-Jaszczuk D; Sehon AH
Cell Immunol; 1993 Aug; 150(1):168-93. PubMed ID: 8343965
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta (TGF-beta)-resistant helper T lymphocyte clones show a concomitant loss of all three types of TGF-beta receptors.
Siepl C; Malipiero UV; Fontana A
J Immunol; 1991 May; 146(9):3063-7. PubMed ID: 1849940
[TBL] [Abstract][Full Text] [Related]
8. Synergy of tumor necrosis factor with protein kinase C activators on T cell activation.
Muñoz-Fernández MA; Pimentel-Muiños FX; Alonso MA; Campanero M; Sánchez-Madrid F; Silva A; Alonso JL; Fresno M
Eur J Immunol; 1990 Mar; 20(3):605-10. PubMed ID: 2318252
[TBL] [Abstract][Full Text] [Related]
9. Involvement of soluble mediator(s) different from interleukin (IL) 1 in the antigen-induced IL 2 receptor expression and proliferation of L3T4+ (CD4+) T lymphocytes.
Germann T; Schmitt E; Huhn H; Rüde E
Eur J Immunol; 1988 Mar; 18(3):459-65. PubMed ID: 3128448
[TBL] [Abstract][Full Text] [Related]
10. Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester.
Albert F; Hua C; Truneh A; Pierres M; Schmitt-Verhulst AM
J Immunol; 1985 Jun; 134(6):3649-55. PubMed ID: 3921610
[TBL] [Abstract][Full Text] [Related]
11. Suppression of antigen-specific T cell responses by Leishmania major excreted factor: inhibition of activation signals linked to the T cell antigen receptor and interleukin 2 receptor.
Isakov N; Tamir A; el-On J
Isr J Med Sci; 1994 Sep; 30(9):673-9. PubMed ID: 8088978
[TBL] [Abstract][Full Text] [Related]
12. Suppressor T cell growth and differentiation: evidence for induced receptors on suppressor T cells that bind a suppressor T cell differentiation factor.
Chu WS; Rich S
J Immunol; 1987 Jan; 138(2):504-12. PubMed ID: 3025299
[TBL] [Abstract][Full Text] [Related]
13. Suppressor T cell circuits in contact sensitivity. III. A monoclonal T cell hybrid-derived suppressor factor specifically suppresses local DTH transfer by a DNP-specific T cell clone.
Miller SD; Jenkins MK
J Immunol; 1986 Mar; 136(5):1571-8. PubMed ID: 2419406
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
Palacios R
Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the immunosuppressive properties of milk growth factor and transforming growth factors beta 1 and beta 2.
Stoeck M; Ruegg C; Miescher S; Carrel S; Cox D; Von Fliedner V; Alkan S
J Immunol; 1989 Nov; 143(10):3258-65. PubMed ID: 2530275
[TBL] [Abstract][Full Text] [Related]
16. Primary activation of murine CD8 T cells via cross-linking of T3 cell surface structures: two signals regulate induction of interleukin 2 responsiveness.
Schmidberger R; Miethke T; Heeg K; Wagner H
Eur J Immunol; 1988 Feb; 18(2):277-82. PubMed ID: 3127221
[TBL] [Abstract][Full Text] [Related]
17. Analysis of T cell-replacing factor-like activity: potent induction of T helper activity for human B cells by residual concanavalin A and interleukin 2.
Sauerwein RW; Van der Meer WG; Aarden LA
Eur J Immunol; 1987 Aug; 17(8):1145-50. PubMed ID: 2957215
[TBL] [Abstract][Full Text] [Related]
18. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
Isakov N; Altman A
J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of interleukin 2-dependent and -independent B cell proliferation with monoclonal anti-interleukin 2 receptor antibody.
Hashimoto N; Nabholz M; MacDonald HR; Zubler RH
Eur J Immunol; 1986 Mar; 16(3):317-20. PubMed ID: 3082653
[TBL] [Abstract][Full Text] [Related]
20. On the mechanisms by which transforming growth factor-beta 2 alters antigen-presenting abilities of macrophages on T cell activation.
Takeuchi M; Kosiewicz MM; Alard P; Streilein JW
Eur J Immunol; 1997 Jul; 27(7):1648-56. PubMed ID: 9247573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
